Cystic fibrosis lung disease: The role of nitric oxide

Pediatric Pulmonology

Volumn 28, Issue 6, 1999, Pages 442-448

  Grasemann, H ^a   Ratjen, F ^a  

^a NONE

Author keywords

Cystic fibrosis; L arginine; Nitrate; Nitric oxide; Nitrite; NO synthases; Pulmonary function; S nitrosothiols

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 2; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN; TETRAHYDROBIOPTERIN; TUMOR NECROSIS FACTOR;

ENZYME METABOLISM; ENZYME SYNTHESIS; GENE ACTIVATION; GENE EXPRESSION; HUMAN; LUNG FIBROSIS; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; REVIEW;

ADOLESCENT; ADULT; AIRWAY RESISTANCE; BRONCHOALVEOLAR LAVAGE FLUID; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HUMANS; LUNG; MALE; NITRIC OXIDE; PROGNOSIS; RESPIRATORY FUNCTION TESTS; SENSITIVITY AND SPECIFICITY;

EID: 0033386691     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199912)28:6<442::AID-PPUL10>3.0.CO;2-4     Document Type: Review

References (65)

1. Wang Y, Marsden PA. Nitric oxide synthases: gene structure and regulation. Adv Pharmacol 1995;34:71-90.
2. Michel T, Feron O. Nitric oxide synthases: which, where, how, and why? J Clin Invest 1997;100:2146-2152.
3. Förstermann U, Boissel J-P, Kleinert H. Expressional control of the "constitutive" isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 1998;12:773-790.
4. Frostell CG, Blomquist H, Hedenstierna G, Lindberg J, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 1993;78:427-435.
5. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405.
6. Högman M, Frostell CG, Hedenstrom H, Hedenstierna G. Inhalation of nitric oxide modulates adult human bronchial tone. Am Rev Respir Dis 1993;148:1474-1478.
7. Sanna A, Kurtansky A, Veriter C, Stranescu D. Bronchodilator effect of inhaled nitric oxide in healthy men. Am J Respir Crit Care Med 1994;150:1702-1704.
8. Roger N, Barbera JA, Farre R, Cobos A, Roca J, Rodriguez-Roisin R. Effect of nitric oxide inhalation on respiratory system resistance in chronic obstructive pulmonary disease. Eur Respir J 1996;9:190-195.
9. Ricciardolo FLM, Geppetti P, Mistretta A, Nadel JA, Sapienza MA, Bellofiore S, DiMaria GU. Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinine-induced asthma. Lancet 1996;348:374-377.
10. Dupuy PM, Shore SA, Drazen JM, Frostell C, Hill WA, Zapol WM. Bronchodilator action of inhaled nitric oxide in guinea pigs. J Clin Invest 1992;90:421-428.
11. Belvisi MG, Stetton CD, Barnes PJ. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in human airways. Eur J Pharmacol 1992;210:221-222.
12. Barnes PJ, Belvisi MG. Nitric oxide and lung disease. Thorax 1993;48:1034-1043.
13. Rada OD, Villaro AC, Montuenga LM, Martinez A, Springall DR, Polak JM. Nitric oxide synthase-immunoreactive neurons in human and porcine respiratory tract. Neurosci Lett 1993;162:121-124.
14. Fischer A, Hoffmann B. Nitric oxide synthase in neurons and nerve fibers of lower airways and in vagal sensory ganglia in man. Correlation with neuropeptides. Am J Respir Crit Care Med 1996; 154:209-216.
15. Jain B, Lubinstein I, Robbins RA, Leise KL, Sisson JH. Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun 1993;191:83-88.
16. Fang FC. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997;99:2818-2825.
17. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997;100:2417-2423.
18. Vallance P, Moncada S. Role of endogenous nitric oxide in septic shock. New Horizon 1993;1:77-87.
19. Gaston B, Drazen JM, Loscalzo J, Stamler JS. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994; 149:538-551.
20. Kharitonov SA, Yates D, Barnes PJ. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur Respir J 1995;8:295-297.
21. Gaston B. Expired nitric oxide in pediatric asthma: emissions testing for children? J Pediatr 1997;131:343-344.
22. Dötsch J, Demirakça S, Terbrack HG, Hüls G, Rascher W, Kühl PG. Airway nitric oxide in asthmatic children and patients with cystic fibrosis. Eur Respir J 1996;9:2537-2540.
23. Lundberg JON, Nordvall SL, Weitzberg E, Kollberg H, Alving K. Exhaled nitric oxide in paediatric asthma and cystic fibrosis. Arch Dis Child 1996;75:323-326.
24. Balfour-Lynn IM, Laverty A, Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child 1996;75:319-322.
25. Grasemann H, Michler E, Wallot M, Ratjen F. Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr Pulmonol 1997;24:173-177.
26. Linnane SJ, Keatings VM, Costello CM, Moynihan JB, O'Connor CM, FitzGerald MX, McLoughlin P. Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am J Respir Crit Care Med 1998;158:207-212.
27. Storme L, Riou Y, Leclerc F, Dubois A, Deschildre A, Pierre MH, Logier R, Robin H, Lequien P. Exhaled nitric oxide (NO) and respiratory function measured with body plethysmography in children. Arch Pediatr 1998;5:389-396.
28. Ho LP, Innes JA, Greening AP. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide. Thorax 1998;53:680-684.
29. Ho LP, Innes JA, Greening AP. Exhaled nitric oxide is not elevated in the inflammatory airway diseases of cystic fibrosis and bronchiectasis. Eur Respir J 1998;12:1290-1294.
30. Grassmann H, Gärtig SS, Wiesemann HG, Teschler H, Konietzko N, Ratjen F. Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome. Eur Respir J 1999;13:114-118.
31. Kharitonov SA, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations. Eur Respir J 1997;10: 1683-1693.
32. Franklin PJ, Taplin R, Stick SM. A community study of exhaled nitric oxide in healthy children. Am J Respir Crit Care Med 1999; 159:69-73.
33. Högrnan M, Stromberg S, Schedin U, Frostell C, Hedenstierna G, Gustafsson LE. Nitric oxide from the human respiratory tract efficiently quantified by standardized single breath measurement. Acta Physiol Scand 1997;159:345-346.
34. Grasemann H, Ioannidis I, Tomkiewicz RP, de Groot H, Rubin BK, Ratjen F. Nitric oxide metabolites in cystic fibrosis lung disease. Arch Dis Child 1998;78:49-53.
35. Grasemann U, Tomkiewicz RP, Ioannidis I, Ramirez OE, Rubin BK, Ratjen F. Metabolites of nitric oxide and viscoelastic properties of airway secretions in cystic fibrosis. Am J Respir Crit Care Med 1997;155:46.
36. Gaston B, Canady R, Robbins M, Goldberg J. Reductive pathways for nitrogen in the cystic fibrosis airway: clinical implication. Pediatr Pulmonol [Suppl] 1998;17:336-337.
37. Gaston B, Reilly J, Drazen JM, Fackler J, Ramdev P, Arnelle D, Mullins ME, Sugarbaker DJ, Chee C, Singel DJ, Loscalzo J, Stamler JS. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci USA 1993; 90:10957-10961.
38. Grasemann H, Ioannidis I, de Groot H, Ratjen F. Metabolites of nitric oxide in the lower respiratory tract of children. Eur J Pediatr 1997;156:575-578.
39. Francoeur C, Denis M. Nitric oxide and interleukin-8 as inflammatory components of cystic fibrosis. Inflammation 1995;19:587-598.
40. Grasemann H, Gaston B, Fang K, Paul K, Ratjen F. Decreased levels of nitrosothiols in the lower airways of cystic fibrosis patients with normal lung function. J Pediatr 1999 (in press).
41. Robbins RA, Barnes PJ, Springall DR, Warren JB, Kwon OJ, Buttery LDK, Wilson AJ, Geller DA, Polak JM. Expression of inducible nitric oxide in human lung epithelial cells. Biochem Biophys Res Commun 1994;203:209-218.
42. Jones KL, Bryan TW, Jinkins PA, Simpson KL, Grisham MB, Owens MW, Milligan SA, Markewitz BA, Robbins RA. Superoxide release from neutrophils causes a reduction in nitric oxide gas. Am J Physiol 1998;275:1120-1126.
43. 4 in serum of patients with cystic fibrosis. Pediatr Asthma Allergy Immunol 1996;10:101-107.
44. Meng QH, Springall DR, Bishop AE, Morgan K, Evans TJ, Habib S, Gruenert DC, Gyi KM, Hodson ME, Yacoub MH, Polak JM. Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J Pathol 1998;184:323-331.
45. Kelley TJ, Drumm ML. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J Clin Invest 1998;102:1200-1207.
46. Belvisi M, Barnes PJ, Larkin S, Yacoub M, Tadjkarimi S, Williams TJ, Mitchell JA. Nitric oxide synthase activity is elevated in inflammatory lung disease in humans. Eur J Pharmacol 1995;283: 255-258.
47. Park E, Quinn MR, Schuller-Levis GB. Taurine chloramine inhibits nitric oxide production, induction of NOS and expression of iNOS mRNA in activated RAW 264.7 cells. J Leukocyte Biol [Suppl] 1994;:32.
48. McCall TB, Palmer RMJ, Moncada S. Interleukin-8 inhibits the induction of nitric oxide synthase in rat peritoneal neutrophils. Biochem Biophys Res Commun 1992;186:680-685.
49. Kelley TJ, van Heeckeren A, Emer HL. Possible involvement of TGF-beta1 in the decreased expression of inducible nitric oxide synthase in CF airway epithelium. Pediatr Pulmonol [Suppl] 1998; 17:288.
50. Malawista SE, Montgomery RR, van Blaricom G. Evidence for reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts. J Clin Invest 1992;90:631-636.
51. Smith AW, Green J, Eden CE, Watson ML. Nitric oxide-induced potentiation of the killing of Burkholderia cepacia by reactive oxygen species: implication for cystic fibrosis. J Med Microbiol 1999;48:419-423.
52. Kamosinska B, Radomski MW, Duszyk M, Radomski A, Man FS. Nitric oxide activates chloride currents in human lung epithelial cells. Am J Physiol 1997;272:1098-1104.
53. Dong YJ, Chao AC, Kouyama K, Hsu YP, Bocian RC, Moss RB, Gardner P. Activation of CFTR chloride current by nitric oxide in human T lymphocytes. EMBO J 1995;14:2700-2707.
54. Elmer HL, Brady KG, Drumm ML, Kelley TJ. Nitric oxide-mediated regulation of transepithelial sodium and chloride transport in murine nasal epithelium. Am J Physiol 1999;276:466-473.
55. Lundberg JON, Weitzberg E, Rinder J, Rudehill A, Jansson O, Widukind NP, Lundberg JM, Alving K. Calcium-independent and steroid-resistant nitric oxide synthase activity in human paranasal sinus mucosa. Eur Respir J 1996;9:1344-1347.
56. Guo FH, De Raeve HR, Rice TW, Struehr DJ, Thunnissen FB, Erzurum SC. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal airway epithelium in vivo. Proc Natl Acad Sci USA 1995;92:7809-7813.
57. Lundberg JON, Settergren G, Gelinder S, Lundberg JM, Alving K, Weitzberg E. Inhalation of nasally derived nitric oxide modulates pulmonary function in humans. Acta Physiol Scand 1996; 158:343-347.
58. Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996;380:21-25.
59. Taylor-Robinson AW, Liew FY, Severn A, Xu D, McSorley SJ, Garside P, Padron J, Phillips RS. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur J Immunol 1994;24:980-984.
60. Solomons CC, Cotton EK, Dubois R. The use of buffered L-arginine in the treatment of cystic fibrosis. Pediatrics 1971;47: 384-390.
61. Dietzsch HJ, Gottschalk B, Heyne K, Leupoid W, Wunderlich P. Cystic fibrosis: comparison of two mucolytic drugs for inhalation treatment (acetylcysteine and arginine hydrochloride). Pediatrics 1975;55:96-100.
62. Kacmarek RM, Ripple R, Cockrill BA, Bloch KJ, Zaplo WM, Johnson DC. Inhaled nitric oxide a bronchodilator in mild asthmatics with methacholine-induced bronchospasm. Am J Resp Crit Care Med 1996;153:128-135.
63. Ratjen F, Gärtig S, Wiesemann HG, Grasemann H. Effect of inhaled nitric oxide on lung function in cystic fibrosis. Respir Med 1999; in press.
64. Gaston B, Drazen JM, Jansen A, Sugarbaker DA, Loscalzo J, Richards W, Stamler JS. Relaxation of human bronchial smooth muscle by S-nitrosothiols in vitro. J Pharmacol Exp Ther 1994; 268:978-984.
65. Gaston B. Nitric oxide and thiol groups. Biochim Biophys Acta 1999;1411:323-333.